Published in Eur J Clin Pharmacol on January 01, 1984
Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide. Br J Clin Pharmacol (1988) 0.90
Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects. Br J Clin Pharmacol (1992) 0.76
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med (1979) 2.48
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet (1989) 2.12
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A (1990) 2.04
Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest (1991) 2.02
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg (1999) 1.85
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet (1992) 1.67
Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet (1975) 1.66
Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr (1985) 1.61
Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract (2004) 1.60
Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol (1975) 1.59
Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment. Am J Dis Child (1986) 1.58
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
Diabetes: mellitus or lipidus? Diabetologia (2003) 1.55
Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child (1988) 1.54
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54
Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet (1986) 1.51
Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology (1998) 1.50
Thrombocytopenia and human immunodeficiency virus in children. Pediatrics (1988) 1.49
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.47
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. Diabetes Metab Res Rev (2013) 1.47
Clinical and immunologic effects of lipid-based parenteral nutrition in AIDS. JPEN J Parenter Enteral Nutr (1992) 1.46
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol (1998) 1.46
Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis (1980) 1.45
Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA (1991) 1.44
High frequency of hemorrhagic strokes in Jerusalem during the Persian Gulf War. Neurology (1992) 1.43
Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. Diabet Med (2005) 1.43
Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature (1975) 1.43
An association between multiple sclerosis and type I diabetes mellitus. J Neurol (1992) 1.42
Lack of hemispheric localizing value of the palmomental reflex. Neurology (2005) 1.40
Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection. Pediatr Infect Dis J (1990) 1.40
Evidence for a major gene affecting the transition from normoglycaemia to hyperglycaemia in Psammomys obesus. Heredity (Edinb) (2005) 1.40
False-negative N.B.T. tests due to transient malfunction of neutrophils. Lancet (1973) 1.40
Alkaline phosphatase band-10 fraction as a possible surrogate marker for human immunodeficiency virus type 1 infection in children. Arch Pathol Lab Med (1994) 1.39
Blood pressure measurement method not responsible for results of Brands et al. Am J Hypertens (1994) 1.39
Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients. J Neurol Sci (1996) 1.38
Activated suppressor T cells in leprosy. J Immunol (1982) 1.37
Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro. Clin Exp Immunol (1978) 1.34
Pediatric AIDS. Curr Probl Pediatr (1986) 1.34
Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 1.27
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med (1994) 1.22
Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Arch Neurol (1986) 1.20
Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med (1977) 1.20
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest (1992) 1.20
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol (1995) 1.18
AIDS: calcification of the basal ganglia in infants and children. Neurology (1986) 1.18
Pericarditis in familial Mediterranean fever. Am J Dis Child (1968) 1.17
Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) (1996) 1.17
Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol (1984) 1.16
Inosiplex in the treatment of subacute sclerosing panencephalitis. Arch Neurol (1979) 1.16
Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. Am J Cardiol (1998) 1.16
Guillain-Barré syndrome after epidural anesthesia: direct nerve root damage may trigger disease. Neurology (1985) 1.16
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med (1985) 1.15
Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest (1988) 1.14
Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol (2001) 1.13
Maggot therapy for the treatment of intractable wounds. Int J Dermatol (1999) 1.13
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract (2009) 1.13
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res (1993) 1.12
Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol (1996) 1.11
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut (1999) 1.11
Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. J Control Release (2001) 1.11
Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest (1980) 1.10
Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex. J Pediatr (1986) 1.10
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest (1991) 1.10
Passive transfer of experimental autoimmune myasthenia by lymph node cells in inbred guinea pigs. J Exp Med (1975) 1.10
Bacterial infection in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis (1985) 1.09
Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients. Isr J Med Sci (1978) 1.09
Hyperglycemia induces accumulation of glucose in human skeletal muscle. Am J Physiol (1991) 1.08
Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol (1994) 1.08
Genetic affinities of Ethiopian Jews. Isr J Med Sci (1991) 1.08
Immunological decay in thymectomized infants. Helv Paediatr Acta (1976) 1.08
Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res (1983) 1.07
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. Mult Scler (2010) 1.07
Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res (1998) 1.06
Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol (1999) 1.06
The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. Mol Pharmacol (2006) 1.06
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Autologous marrow reconstitutions in severe aplastic anaemia after ALG pretreatment and HL-A semi-incompatible bone marrow cell transfusion. Acta Haematol (1976) 1.04
Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc Natl Acad Sci U S A (1975) 1.03
Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol (1990) 1.03
Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol (1990) 1.02
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol (1999) 1.02
Clinical comparison of frequency doubling technology perimetry and Humphrey perimetry. Br J Ophthalmol (2001) 1.01
Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis (1986) 1.01
Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor. Arch Neurol (1975) 1.01
Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am J Dis Child (1989) 1.01
T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun (1999) 1.01
Effect of two approaches to auditory training on speech recognition by hearing-impaired adults. J Speech Hear Res (1987) 1.01
Association of MS with thyroid disorders. Neurology (1999) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
Immunohistochemical changes in morphologically involved and uninvolved colonic mucosa of patients with idiopathic proctitis. J Clin Invest (1977) 1.00